I think NMS is a good buy for a bad market day; on any other day it would have opened @ .65 (currently .55) after this announcement; IMO. DYOR.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%